Cresco Labs (CRLBF) Receivables (2019 - 2026)

Cresco Labs has reported Receivables for 8 years, with the latest figure at $38.1 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables changed N/A year-over-year to $38.1 million; the trailing twelve-month figure through Mar 2026 stood at $38.1 million (changed N/A YoY), and the FY2025 full-year result was $37.9 million, changed N/A from the prior year.
• Receivables for Q1 2026 stood at $38.1 million, up from $37.9 million in the prior quarter.
• The five-year high for Receivables was $59.0 million in Q4 2023, with the low at $37.9 million in Q4 2025.
• Historically, Receivables has averaged $48.8 million across 5 years, with a median of $49.8 million in 2024.
• The largest YoY upside for Receivables was 37.01% in 2022 against a maximum downside of 37.01% in 2022.
• Cresco Labs' Receivables stood at $51.6 million in 2022, then advanced by 14.3% to $59.0 million in 2023, then fell by 7.58% to $54.6 million in 2024, then sank by 30.56% to $37.9 million in 2025, then climbed by 0.69% to $38.1 million in 2026.
• The last three Receivables figures came in at $38.1 million (Q1 2026), $37.9 million (Q4 2025), and $54.6 million (Q3 2024), per Business Quant data.